Haemonetics (HAE) FCF Margin (2009 - 2026)

Haemonetics' FCF Margin history runs 18 years deep, the most recent figure standing at 15.38% for Q1 2026.

• On a quarterly basis, FCF Margin fell 1514.0% year-over-year to 15.38% in Q1 2026; TTM through Mar 2026 was 19.52%, a 906.0% increase from a year earlier, with the FY2026 full-year figure at 19.52%, up 906.0% from the prior year.
• FCF Margin fell to 15.38% in Q1 2026 per HAE's latest filing, from 25.73% in the prior quarter.
• Across five years, FCF Margin topped out at 32.48% in Q3 2025 and bottomed at 9.84% in Q2 2024.
• The 5-year median for FCF Margin is 13.1% (2022), against an average of 12.08%.
• Across the five-year window, FCF Margin tumbled 2010 bps in 2023 and jumped 2114 bps in 2024, its largest moves.
• Year by year, FCF Margin stood at 15.58% in 2022, then tumbled by 129 bps to 4.52% in 2023, then jumped by 324 bps to 10.1% in 2024, then surged by 155 bps to 25.73% in 2025, then plunged by 40 bps to 15.38% in 2026.
• Per Business Quant, the three latest HAE FCF Margin figures stand at 15.38% (Q1 2026), 25.73% (Q4 2025), and 32.48% (Q3 2025).